Health IT Analytics February 5, 2021
Jessica Kent

The precision medicine study will aim to help children access treatments and potential cures for genetic disorders based on their DNA.

Intermountain Primary Children’s Hospital has launched the HerediGene: Children’s Study, an effort to speed the development of precision medicine therapies for children with genetic disorders.

The HerediGene: Children’s Study is the world’s largest DNA mapping effort ever undertaken in kids. The study will involve the voluntary collection of 50,000 DNA samples of children as young as newborns, as well as their parents and siblings who choose to participate.

The study will seek to help children find future treatments and possible cures for genetic disorders based on their unique DNA.

Data from the study will help researchers at the Primary...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health System / Hospital, Pharma / Biotech, Precision Medicine, Provider
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article